Patent · US Active

Methods of using IL-17 receptor a antibodies

US8435518B2 · kind B2 · utility

7Cited by
24References
65Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2010
Grant dateMay 7, 2013
Priority date
Expiry dateSep 3, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.